A Post-Market Clinical Evaluation of the Treatment of Femur Fractures with the Femoral Nail Greater Trochanter (GT) of the T2 Alpha Femur Antegrade GT/PF Nailing System

Brief description of study

The purpose of this study is to show the safety and performance of the T2 Alpha Femur Antegrade Greater Trochanter (GT) Nail. Participants will be those who will have surgery for their femur fracture and their surgeon will be using the T2 Alpha Femur Antegrade Greater Trochanter (GT) Nail device as part of their planned standard of care. This device is not an experimental medical device and is approved by the United States Food and Drug Administration (FDA).

Clinical Study Identifier: s18-00733
ClinicalTrials.gov Identifier: NCT04015128
Principal Investigator: Nirmal C Tejwani.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.